中财网 中财网股票行情
恩威医药(301331)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)56034.1138814.9518347.5978519.1356988.51
营业收入(万元)56034.1138814.9518347.5978519.1356988.51
营业总成本(万元)53660.7336846.9817503.8369890.7949737.67
营业成本(万元)27483.6918679.769126.0038274.0728155.58
净利润(万元)2202.201793.44842.398631.237293.50
归属于母公司的净利润(万元)2202.201793.44842.398631.237293.50
营业利润(万元)2853.332334.911049.2610172.698487.37
利润总额(万元)2552.262293.791049.2010131.478513.16
少数股东损益(万元)----------
基本每股收益(元)0.22(元)0.18(元)0.12(元)1.23(元)0.71(元)
稀释每股收益(元)0.22(元)0.18(元)0.12(元)1.23(元)0.71(元)
非经常性损益(万元)157.89276.00174.371272.73--
扣除非经常性损益后净利润(万元)2044.301517.45668.027358.506098.01
总资产(万元)142289.46147132.59135553.74133749.77131843.04
总负债(万元)40093.0445776.5327598.5423431.1820471.35
归属于母公司股东权益合计(万元)102196.41101356.06107955.20110318.59111371.69
股东权益合计(万元)102196.41101356.06107955.20110318.59111371.69
实收资本(股本)(万元)10289.1910289.197013.847013.847013.84
资本公积(万元)66105.6665454.0967940.1367150.8266463.36
未分配利润(万元)32470.0332061.2836567.7035725.3134387.58
经营活动产生的现金流量净额(万元)7146.459027.10606.698401.115023.81
经营活动现金流入小计(万元)56708.5042327.0017125.2872853.9854798.53
经营活动现金流出小计(万元)49562.0533299.9016518.5964452.8749774.72
投资活动产生的现金流量净额(万元)-1348.463078.54-1305.22-4417.564527.81
投资活动现金流入小计(万元)64060.3544244.9321836.2277537.3756937.02
投资活动现金流出小计(万元)65408.8141166.3923141.4481954.9352409.21
筹资活动产生的现金流量净额(万元)7163.229653.96-814.44-14522.18-11224.94
筹资活动现金流入小计(万元)24180.0024180.003300.00----
筹资活动现金流出小计(万元)17016.7814526.044114.4414522.1811224.94
期末现金及现金等价物余额(万元)36542.8945341.2822068.7123581.6832447.00
最后修改日期2024-10-242024-08-302024-04-232024-04-222024-10-23
↑返回页顶↑

转至恩威医药（301331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。